Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio IP Ventures II LLC is a specialized investment vehicle and special purpose vehicle (SPV) managed by Hudson Bay Capital Management LP. The entity focuses on providing structured financing, venture debt, and strategic capital to companies within the life sciences, biotechnology, and medical device sectors. It has notably served as a collateral agent and major stakeholder for companies such as Neovasc Inc. and ImmunityBio (formerly NantKwest), holding security interests in key cardiovascular and oncology assets. Its investment strategy typically involves securing intellectual property and other core assets as collateral for high-growth healthcare innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio IP Ventures II.